BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28124769)

  • 21. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
    Moelans CB; Milne AN; Morsink FH; Offerhaus GJ; van Diest PJ
    Cell Oncol (Dordr); 2011 Apr; 34(2):89-95. PubMed ID: 21394646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of HER2 gene amplification and protein expression in gastric cancer.
    Yan B; Yau EX; Bte Omar SS; Ong CW; Pang B; Yeoh KG; Salto-Tellez M
    J Clin Pathol; 2010 Sep; 63(9):839-42. PubMed ID: 20696687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.
    van Rooijen JM; de Munck L; de Graaf JC; Siesling S; de Vries EG; Boers JE
    Eur J Cancer; 2014 Mar; 50(5):885-91. PubMed ID: 24491395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival.
    Subasinghe D; Sivaganesh S; Samarsekera A; Kumarasinghe MP; Samarasekera DN; Lokuhetty MDS
    Dig Dis Sci; 2017 Sep; 62(9):2498-2510. PubMed ID: 28612195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
    Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
    Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.
    Laboissiere RS; Buzelin MA; Balabram D; De Brot M; Nunes CB; Rocha RM; Cabral MM; Gobbi H
    BMC Gastroenterol; 2015 Nov; 15():157. PubMed ID: 26530403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material.
    Ciesielski M; Kruszewski WJ; Śmiałek U; Walczak J; Szajewski M; Szefel J; Wydra J; Kawecki K
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):113-7. PubMed ID: 25203430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HER2 expression in gastric cancer in Peru].
    Beltran Gárate B; Yabar Berrocal A
    Rev Gastroenterol Peru; 2010; 30(4):324-7. PubMed ID: 21263759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1).
    Park SR; Park YS; Ryu MH; Ryoo BY; Woo CG; Jung HY; Lee JH; Lee GH; Kang YK
    Eur J Cancer; 2016 Jan; 53():42-50. PubMed ID: 26693898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer.
    Seo KW; Jeon T; Kim S; Kim SS; Kim K; Suh BJ; Hwang S; Choi S; Ryu S; Min JS; Lee YJ; Jee YS; Chae H; Yang DH; Lee SH
    J Gastric Cancer; 2017 Mar; 17(1):52-62. PubMed ID: 28337363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.
    Sasaki T; Fuse N; Kuwata T; Nomura S; Kaneko K; Doi T; Yoshino T; Asano H; Ochiai A; Komatsu Y; Sakamoto N; Ohtsu A
    Jpn J Clin Oncol; 2015 Jan; 45(1):43-8. PubMed ID: 25378649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study.
    Huang D; Lu N; Fan Q; Sheng W; Bu H; Jin X; Li G; Liu Y; Li X; Sun W; Zhang H; Li X; Zhou Z; Yan M; Wang X; Sha W; Ji J; Cheng X; Zhou Z; Xu J; Du X
    PLoS One; 2013; 8(11):e80290. PubMed ID: 24244671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
    Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
    Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2 testing in gastric cancer: An update.
    Abrahao-Machado LF; Scapulatempo-Neto C
    World J Gastroenterol; 2016 May; 22(19):4619-25. PubMed ID: 27217694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial).
    Matsumoto T; Sasako M; Mizusawa J; Hirota S; Ochiai A; Kushima R; Katai H; Tanaka Y; Fukushima N; Nashimoto A; Tsuburaya A;
    Gastric Cancer; 2015 Jul; 18(3):467-75. PubMed ID: 24993498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
    Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
    J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.
    Cruz-Reyes C; Gamboa-Dominguez A
    Int J Surg Pathol; 2013 Jun; 21(3):240-6. PubMed ID: 23564704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.